Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-02-11T09:09:46.911Z Has data issue: false hasContentIssue false

A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane

With Notes on the Stroboscopic Phenomenon

Published online by Cambridge University Press:  08 February 2018

Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

3,4,5-Trimethoxyphenyl-β-aminopropane (TMA) is structurally related to both amphetamine and mescaline, as is shown in Figure 1.

Because of this structural relationship of TMA and amphetamine, methedrine, and mescaline, one could anticipate a clinical response to the compound which would represent certain phenomena characteristic of each of these drugs. This presented an intriguing problem as to whether or not, in actuality, this would be the case.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1955 

References

Blaschko, H., Nature, 1940, 145, 26.Google Scholar
Chaumerliac, and Roche, , Lyon Méd., 1949, 182, 167.Google Scholar
Fischer, R., J. Ment. Sci., 1954, 100, 623.Google Scholar
Grahn, H. V., Am. Pract. Dig. of Treat., August 1950, 795.Google Scholar
Hey, P., Quart. J. Pharm. Pharmacol., 1947, 20, 129.Google Scholar
Liddell, D. W., and Weil-Malherbe, H., J. Neur. Neurosurg. Psychiat., 1953, 16, 7.CrossRefGoogle Scholar
Stockings, G. T., J. Ment. Sci., 1940, 86, 29.Google Scholar
Woods, L. A., Cochin, J., Fornefeld, E. J., McMahon, F. G., and Seevers, M. H., J. Pharm. Exper. Therap., 1951, 101, 188.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.